Transcript
![Page 1: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/1.jpg)
![Page 2: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/2.jpg)
![Page 3: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/3.jpg)
![Page 4: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/4.jpg)
![Page 5: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/5.jpg)
![Page 6: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/6.jpg)
![Page 7: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/7.jpg)
![Page 8: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/8.jpg)
![Page 9: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/9.jpg)
![Page 10: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/10.jpg)
![Page 11: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/11.jpg)
![Page 12: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/12.jpg)
![Page 13: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/13.jpg)
II.F.10. Concern Regarding Potential Effect of
Complexity of Adverse Event Reporting Process on Ascertainment
·
·
·
·
Please see the event reporting flow diagrams in Figures II.B.4 and II.B.5.
![Page 14: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/14.jpg)
![Page 15: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/15.jpg)
![Page 16: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/16.jpg)
•
•
•
•
•
![Page 17: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/17.jpg)
•
•
•
•
![Page 18: Addressing the Challenges of Safety Data Collection in Clinical Studies](https://reader031.vdocuments.us/reader031/viewer/2022030312/58edf33a1a28abe92d8b460d/html5/thumbnails/18.jpg)
II.F.10. Concern Regarding Potential Effect of
Complexity of Adverse Event Reporting Process on Ascertainment
·
·
·
·
Please see the event reporting flow diagrams in Figures II.B.4 and II.B.5.
•
•
•
•
•
•
•
•
•